| 000 | 01852 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250515013929.0 | ||
| 264 | 0 | _c20061206 | |
| 008 | 200612s 0 0 eng d | ||
| 022 | _a0304-3835 | ||
| 024 | 7 |
_a10.1016/j.canlet.2005.11.041 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aArnold, Katrin | |
| 245 | 0 | 0 |
_aLower level of BRCA2 protein in heterozygous mutation carriers is correlated with an increase in DNA double strand breaks and an impaired DSB repair. _h[electronic resource] |
| 260 |
_bCancer letters _cNov 2006 |
||
| 300 |
_a90-100 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aBRCA2 Protein _xgenetics |
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 |
_aBreast Neoplasms _xgenetics |
| 650 | 0 | 4 |
_aBreast Neoplasms, Male _xgenetics |
| 650 | 0 | 4 |
_aCell Cycle _xgenetics |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aComet Assay |
| 650 | 0 | 4 |
_aDNA _xchemistry |
| 650 | 0 | 4 |
_aDNA Damage _xgenetics |
| 650 | 0 | 4 | _aDNA Mutational Analysis |
| 650 | 0 | 4 |
_aDNA Repair _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aFluorescent Antibody Technique |
| 650 | 0 | 4 | _aGamma Rays |
| 650 | 0 | 4 |
_aHaplotypes _xgenetics |
| 650 | 0 | 4 | _aHeterozygote |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMitomycin _xpharmacology |
| 650 | 0 | 4 |
_aMutation _xdrug effects |
| 650 | 0 | 4 | _aPedigree |
| 650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
| 650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
| 700 | 1 | _aKim, Min-Kyoung | |
| 700 | 1 | _aFrerk, Katrin | |
| 700 | 1 | _aEdler, Lutz | |
| 700 | 1 | _aSavelyeva, Larissa | |
| 700 | 1 | _aSchmezer, Peter | |
| 700 | 1 | _aWiedemeyer, Ruprecht | |
| 773 | 0 |
_tCancer letters _gvol. 243 _gno. 1 _gp. 90-100 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.canlet.2005.11.041 _zAvailable from publisher's website |
| 999 |
_c16062624 _d16062624 |
||